CXCL13 blockade abrogates bone metastasis by impairing beta-3 integrin activation and matrix metalloproteinase expression by prostate cancer cells (98.4)
Year: 2009
Type: conference-abstract
Source: The Journal of Immunology
Institution: University of Louisville
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W94342469
